Please check your internet connection and try again.
# Miconazole Vaginal Pessary
## Overview
Miconazole is an imidazole antifungal agent. Vaginal pessaries are solid dosage forms inserted into the vagina for localized treatment.
## Primary Indications
Treatment of vulvovaginal candidiasis (yeast infection).
## Adult Dosing
* **100 mg vaginal pessary:** Insert one pessary vaginally at bedtime for 7 consecutive days.
* **200 mg vaginal pessary:** Insert one pessary vaginally at bedtime for 3 consecutive days.
* **Single-dose 1200 mg vaginal suppository:** Insert one suppository vaginally at bedtime. (Note: This is a suppository, not a pessary, but often grouped with vaginal antifungal treatments.)
Maximum daily dose for vaginal administration is generally limited by the available dosage forms; typically, the 1200 mg single dose is the highest available.
## Pediatric Dosing
Information on the use of miconazole vaginal pessaries in pediatric populations is limited. Clinical use in children is generally not recommended without specific expert guidance due to lack of established safety and efficacy data.
## Dose Adjustments
No dose adjustments are typically required for renal or hepatic impairment for topical vaginal administration.
## Contraindications
* Hypersensitivity to miconazole or any component of the formulation.
## Adverse Effects
* **Common:** Vaginal burning, itching, irritation, pelvic cramps.
* **Less Common:** Headache, rash.
## Key Drug Interactions
* **Warfarin:** Miconazole (especially oral, but systemic absorption from vaginal products, though minimal, is theoretically possible) can inhibit CYP2C9 and CYP3A4, increasing warfarin levels and the risk of bleeding. Monitor INR closely if used concurrently.
* **CYP3A4 Substrates:** Miconazole can inhibit CYP3A4, potentially increasing concentrations of drugs metabolized by this enzyme (e.g., some statins, calcium channel blockers, immunosuppressants).
## Monitoring
* Monitor for symptom improvement.
* Assess for local irritation or allergic reaction.
* If signs of systemic absorption or drug interactions occur, further monitoring may be warranted.
## Clinical Pearls
* Complete the full course of treatment as prescribed, even if symptoms improve sooner.
* Avoid sexual intercourse during treatment.
* Pessaries may weaken latex condoms and diaphragms, increasing the risk of breakage or slippage. Advise patients to use alternative birth control methods during treatment and for at least 72 hours after completion.
* Patient education on proper insertion technique is important.
***
*This information is intended for clinical use and does not replace comprehensive drug information resources. Always verify current prescribing information and consult relevant guidelines before making clinical decisions.*
